Genetics of the Framingham Heart Study population

scientific article

Genetics of the Framingham Heart Study population is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/S0065-2660(08)00602-0
P932PMC publication ID3014216
P698PubMed publication ID19010253

P50authorWilliam B. KannelQ15439387
Ralph B. D'Agostino Sr.Q59209521
Daniel LevyQ88264418
Christopher J O'DonnellQ89928448
Diddahally R GovindarajuQ90272647
Caroline S. FoxQ90412599
Greta Lee SplanskyQ114427803
Larry D AtwoodQ124253966
Joanne M MurabitoQ47502296
Emelia J. BenjaminQ28754501
Ramachandran S. VasanQ30348351
L. Adrienne CupplesQ37638868
Philip A WolfQ42561276
P2093author name stringMarty Larson
P2860cites workPrediction of Coronary Heart Disease Using Risk Factor CategoriesQ22241923
Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common diseaseQ22337234
The Interaction of Selection and Linkage. I. General Considerations; Heterotic ModelsQ24533319
Cardiology's 10 greatest discoveries of the 20th centuryQ24533369
Complement factor H polymorphism in age-related macular degenerationQ24553334
Genomewide linkage analysis of body mass index across 28 years of the Framingham Heart StudyQ24632395
The incidence of alkaptonuria: a study in chemical individuality. 1902 [classical article]Q24652974
A haplotype map of the human genomeQ24679827
Sex and age specific effects of chromosomal regions linked to body mass index in the Framingham Study.Q25256864
Genome scan for quantity of hand osteoarthritis: The Framingham studyQ57244894
Genome-Wide Linkage to Chromosome 6 for Waist Circumference in the Framingham Heart StudyQ57282135
Homozygous Tangier disease and cardiovascular diseaseQ57337269
Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus Relationships with lipids, apolipoproteins, and premature coronary artery diseaseQ57337302
Temporal Trends in Coronary Heart Disease Mortality and Sudden Cardiac Death From 1950 to 1999Q57740477
Heritability of Heart Rate VariabilityQ57740609
Genetic and Environmental Contributions to Atherosclerosis Phenotypes in Men and WomenQ57745943
Association of C-Reactive Protein With Carotid Atherosclerosis in Men and Women: The Framingham Heart StudyQ57745951
Relationship of Family History Scores for Stroke and Hypertension to Quantitative Measures of White-Matter Hyperintensities and Stroke Volume in Elderly MalesQ57745997
Heritability of the Ankle-Brachial IndexQ57747586
Genome-wide linkage analysis to age at natural menopause in a community-based sample: the Framingham Heart StudyQ57747592
Genetic and environmental contributions to atherosclerosis phenotypes in men and women: heritability of carotid intima-media thickness in the Framingham Heart StudyQ57798867
Evidence for Heritability of Abdominal Aortic Calcific Deposits in the Framingham Heart StudyQ57798894
Healthy People 2000. The rationale and potential efficacy of preventive nutrition in heart disease: the Framingham Offspring-Spouse StudyQ57799025
An investigation of coronary heart disease in families. The Framingham offspring studyQ59461737
Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham studyQ68437927
HLA associations with obesityQ69394279
Serum total homocysteine and coronary heart diseaseQ70870288
Familial aggregation of lens opacities: the Framingham Eye Study and the Framingham Offspring Eye StudyQ72144216
Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart StudyQ72779135
Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease preventionQ73306507
Alcohol drinking determines the effect of the APOE locus on LDL-cholesterol concentrations in men: the Framingham Offspring StudyQ73684114
Epidemiological approaches to heart disease: the Framingham StudyQ75689289
Framingham: the town with heartQ77355008
Lipoprotein(a)-cholesterol and coronary heart disease in the Framingham Heart StudyQ77943779
Age, gender, and body mass effects on quantitative trait loci for bone mineral density: the Framingham StudyQ78756682
The Framingham study: a prospective study of coronary heart diseaseQ78941708
Some factors associated with the development of coronary heart disease: six years' follow-up experience in the Framingham studyQ79207539
Cigarette smoking and coronary heart disease. Combined experience of the Albany and Framingham studiesQ79379361
Open-access database of candidate associations from a genome-wide SNP scan of the Framingham Heart StudyQ79686648
Insurance, unfair discrimination, and genetic testingQ81194228
Linkage disequilibrium and the mapping of complex human traitsQ47593824
Heritability and genetic linkage of plasma natriuretic peptide levelsQ47810782
Bishop lecture. Contribution of the Framingham Study to preventive cardiologyQ48523358
Evidence for a Mendelian gene in a segregation analysis of generalized radiographic osteoarthritis: the Framingham Study.Q50882375
Segregation analysis of pulmonary function among families in the Framingham Study.Q50885975
Heritability of left ventricular mass: the Framingham Heart Study.Q50924384
Heritability and a genome-wide linkage scan for arterial stiffness, wave reflection, and mean arterial pressure: the Framingham Heart Study.Q51411799
A genome-wide scan of pulmonary function measures in the National Heart, Lung, and Blood Institute Family Heart Study.Q51682107
Genetic variation in white matter hyperintensity volume in the Framingham Study.Q51997593
Evolution of morphological integration. I. Functional units channel stress-induced variation in shrew mandibles.Q52088532
Established risk factors and coronary artery disease: the Framingham Study.Q52374975
Fibrinogen and risk of cardiovascular disease. The Framingham Study.Q52588834
Banning genetic discrimination.Q52981673
Genetic nondiscrimination.Q53621214
Reporting genetic results in research studies: summary and recommendations of an NHLBI working group.Q55041761
Enzyme Polymorphisms in ManQ56267425
Association of Parental Heart Failure with Risk of Heart Failure in OffspringQ57073040
Contribution of Clinical Correlates and 13 C-Reactive Protein Gene Polymorphisms to Interindividual Variability in Serum C-Reactive Protein LevelQ57073061
Association of Estrogen Receptor β Gene Polymorphisms With Left Ventricular Mass and Wall Thickness in WomenQ57073092
Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: Evidence for susceptibility loci on 1qQ57073109
Statistical false positive or true disease pathway?Q57120031
Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart StudyQ28236421
Construction of a genetic linkage map in man using restriction fragment length polymorphismsQ28263594
The future of genetic studies of complex human diseasesQ29547215
Atrial fibrillation as an independent risk factor for stroke: the Framingham StudyQ29614200
Genome-wide association studies for common diseases and complex traitsQ29615822
Genome-wide scan on plasma triglyceride and high density lipoprotein cholesterol levels, accounting for the effects of correlated quantitative phenotypesQ31048968
Genetic analysis of common factors underlying cardiovascular disease-related traitsQ31049015
Multivariate sib-pair linkage analysis of longitudinal phenotypes by three step-wise analysis approachesQ31049088
Phenotypic, genetic, and genome-wide structure in the metabolic syndromeQ31049211
Age-stratified heritability estimation in the Framingham Heart Study familiesQ33198458
Evidence for bivariate linkage of obesity and HDL-C levels in the Framingham Heart StudyQ33198468
Phenotype-genotype association grid: a convenient method for summarizing multiple association analysesQ33244250
Genomewide linkage analysis for internal carotid artery intimal medial thickness: evidence for linkage to chromosome 12.Q33909610
Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart studyQ33922221
Plasma homocysteine as a risk factor for dementia and Alzheimer's diseaseQ33957399
Definition of the phenotypeQ34063984
Hypervariable 'minisatellite' regions in human DNA.Q34192489
A multivariate analysis of the risk of coronary heart disease in FraminghamQ34243631
Parental atrial fibrillation as a risk factor for atrial fibrillation in offspringQ34327141
A comparison of linkage disequilibrium measures for fine-scale mappingQ34385088
Biomarkers of cardiovascular disease: molecular basis and practical considerationsQ34526561
Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham StudyQ34539702
Genes, environment and the value of prospective cohort studiesQ34567044
Patterns of linkage disequilibrium in the human genomeQ34609904
Drosophila bristles and the nature of quantitative genetic variationQ35038015
Genetic associations in large versus small studies: an empirical assessmentQ35070873
Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reactionQ35247229
Mapping complex disease loci in whole-genome association studiesQ35784516
Family history of myocardial infarction as an independent risk factor for coronary heart diseaseQ36756717
QT interval is a heritable quantitative trait with evidence of linkage to chromosome 3 in a genome-wide linkage analysis: The Framingham Heart StudyQ39714630
Heritability and correlates of intercellular adhesion molecule-1 in the Framingham Offspring StudyQ40498881
Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspringQ40511049
Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart StudyQ40532486
Genetic and environmental contributions to platelet aggregation: the Framingham heart study.Q40700314
Alcohol and coronary heart disease: the evidence for a protective effect.Q41117045
Maximum-likelihood estimation of gene location by linkage disequilibriumQ41984235
"A change of heart: how the people of framingham, massachusetts, helped unravel the mysteries of cardiovascular disease".Q42939467
Evidence for a gene influencing haematocrit on chromosome 6q23-24: genomewide scan in the Framingham Heart StudyQ43073506
Common variants in the gene encoding ATP-binding cassette transporter 1 in men with low HDL cholesterol levels and coronary heart diseaseQ43546752
Association of the Ala54-Thr polymorphism in the intestinal fatty acid-binding protein with 2-h postchallenge insulin levels in the Framingham Offspring StudyQ43651858
Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigationQ43742848
Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring StudyQ43745376
Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart StudyQ43800923
Association between the PPARA L162V polymorphism and plasma lipid levels: the Framingham Offspring StudyQ43989984
Genome screen for quantitative trait loci contributing to normal variation in bone mineral density: the Framingham StudyQ44125439
Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism: evidence of a strong dose effect in this gene-nutrient interaction in the Framingham Study.Q44196695
Blood pressure aggregation in familiesQ44576485
Parental history is an independent risk factor for coronary artery disease: the Framingham StudyQ44609602
Association between estrogen receptor alpha gene variation and cardiovascular diseaseQ44643928
Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics SubcommitteeQ45002081
Genomewide linkage analysis to serum creatinine, GFR, and creatinine clearance in a community-based population: the Framingham Heart StudyQ45038717
Multiple biomarkers and the risk of incident hypertensionQ45179922
A multivariate family-based association test using generalized estimating equations: FBAT-GEE.Q45289835
Family patterns of coronary heart disease mortality: the Framingham Longevity StudyQ46368322
Genome-wide linkage analyses and candidate gene fine mapping for HDL3 cholesterol: the Framingham StudyQ46417765
Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategiesQ46533556
Homocysteine and cognitive performance in the Framingham offspring study: age is importantQ46656457
Evolution of sickle variant geneQ46672337
A common genetic variant is associated with adult and childhood obesityQ46726890
A COMPARISON OF GENETIC AND PHENOTYPIC CORRELATIONS.Q47376829
Genomewide linkage analysis of weight change in the Framingham Heart StudyQ47388470
P304page(s)33-65
P577publication date2008-01-01
P1433published inAdvances in GeneticsQ26842228
P1476titleGenetics of the Framingham Heart Study population
P478volume62

Reverse relations

cites work (P2860)
Q52322320A genome-wide association study of red-blood cell fatty acids and ratios incorporating dietary covariates: Framingham Heart Study Offspring Cohort.
Q35118206A genome-wide association study of saturated, mono- and polyunsaturated red blood cell fatty acids in the Framingham Heart Offspring Study
Q50702939A systems analysis of age-related changes in some cardiac aging traits.
Q37533800Age, gender, and cancer but not neurodegenerative and cardiovascular diseases strongly modulate systemic effect of the Apolipoprotein E4 allele on lifespan
Q47345577Analyzing metabolomics data for association with genotypes using two-component Gaussian mixture distributions
Q35464461Assessment of whole-genome regression for type II diabetes
Q37141241Association between SNP heterozygosity and quantitative traits in the Framingham Heart Study
Q33957027Beta2-adrenergic receptor gene polymorphisms as systemic determinants of healthy aging in an evolutionary context
Q35752147Birth Cohort, Age, and Sex Strongly Modulate Effects of Lipid Risk Alleles Identified in Genome-Wide Association Studies
Q33813557Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.
Q36439315Burden of rare sarcomere gene variants in the Framingham and Jackson Heart Study cohorts
Q47671871Causal effects of cardiovascular risk factors on onset of major age-related diseases: A time-to-event Mendelian randomization study
Q22066304Colloquium papers: Natural selection in a contemporary human population
Q94336563Coordinated Action of Biological Processes during Embryogenesis Can Cause Genome-Wide Linkage Disequilibrium in the Human Genome and Influence Age-Related Phenotypes
Q33956296Efficient generalized least squares method for mixed population and family-based samples in genome-wide association studies.
Q30604287Evidence for cost-effectiveness of lifestyle primary preventions for cardiovascular disease in the Asia-Pacific Region: a systematic review
Q24620612Evolution in health and medicine Sackler colloquium: Genetic variation in human telomerase is associated with telomere length in Ashkenazi centenarians
Q91826024Extended methods for gene-environment-wide interaction scans in studies of admixed individuals with varying degrees of relationships
Q24634042Eyes wide open: the personal genome project, citizen science and veracity in informed consent
Q30497912Gene by sex interaction for measures of obesity in the framingham heart study
Q38618564Genome-Wide Interaction Study of Omega-3 PUFAs and Other Fatty Acids on Inflammatory Biomarkers of Cardiovascular Health in the Framingham Heart Study.
Q30484496Genome-wide association study of Lp-PLA(2) activity and mass in the Framingham Heart Study
Q36670131Genomics of human health and aging
Q34221082Heritability and genetic correlations explained by common SNPs for metabolic syndrome traits
Q47114556Identification of polymorphisms in cancer patients that differentially affect survival with age.
Q44506890Influences of FTO gene on onset age of adult overweight
Q36027981Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease
Q36670167Inter-chromosomal level of genome organization and longevity-related phenotypes in humans
Q38768989Invited Commentary: The Framingham Offspring Study-A Pioneering Investigation Into Familial Aggregation of Cardiovascular Risk
Q28540586Large scale analysis of phenotype-pathway relationships based on GWAS results
Q36459374Limitations of GCTA as a solution to the missing heritability problem
Q37393450Maintaining physiological state for exceptional survival: What is the normal level of blood glucose and does it change with age?
Q37707119Methods for optimizing statistical analyses in pharmacogenomics research
Q33888869Mind the dbGAP: the application of data mining to identify biological mechanisms
Q37612414Nutrient and food intakes of middle-aged adults at low risk of cardiovascular disease: the international study of macro-/micronutrients and blood pressure (INTERMAP).
Q97884550Nutrigenetics-personalized nutrition in obesity and cardiovascular diseases
Q33605821Nutrigenomics in cardiovascular medicine
Q31037300PHENOME-WIDE INTERACTION STUDY (PheWIS) IN AIDS CLINICAL TRIALS GROUP DATA (ACTG).
Q33679969Pharmacogenetics and personal genomes
Q34150453Phenomics: the next challenge
Q36188430Pleiotropic Associations of Allelic Variants in a 2q22 Region with Risks of Major Human Diseases and Mortality
Q37334893Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases
Q34152260Polymorphisms in the ACE and ADRB2 genes and risks of aging-associated phenotypes: the case of myocardial infarction
Q90362236Quantitative and qualitative role of antagonistic heterogeneity in genetics of blood lipids
Q33704011Screening strategies for cardiovascular disease in asymptomatic adults
Q42684890SeqSIMLA2: simulating correlated quantitative traits accounting for shared environmental effects in user-specified pedigree structure
Q52332981Strong impact of natural-selection-free heterogeneity in genetics of age-related phenotypes.
Q36337875Structured mating: Patterns and implications
Q34994823The MYH9/APOL1 region and chronic kidney disease in European-Americans
Q37721496The effects of acute and chronic exercise on the vasculature
Q36698762The role of lipid-related genes, aging-related processes, and environment in healthspan
Q36638570Trade-off in the effect of the APOE gene on the ages at onset of cardiocascular disease and cancer across ages, gender, and human generations
Q34981216Trade-off in the effects of the apolipoprotein E polymorphism on the ages at onset of CVD and cancer influences human lifespan
Q34222645Trade-offs between cancer and other diseases: do they exist and influence longevity?

Search more.